Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention. - Suppr | 超能文献

Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention.

作者信息

Pappas Christos, Ntai Konstantina, Parissis John T, Anastasiou-Nana Maria

出版信息

Int J Cardiol. 2013 May 10;165(2):380-2. doi: 10.1016/j.ijcard.2012.08.024. Epub 2012 Sep 11.

DOI:10.1016/j.ijcard.2012.08.024

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention.

Int J Cardiol. 2013 May 10;165(2):380-2. doi: 10.1016/j.ijcard.2012.08.024. Epub 2012 Sep 11.

2

Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin.葡萄糖-6-磷酸脱氢酶（G6PD）缺乏症与急性冠状动脉综合征患者的抗血小板和侵入性治疗。阿司匹林的安全性。

J Clin Pharm Ther. 2015 Jun;40(3):349-52. doi: 10.1111/jcpt.12262. Epub 2015 Mar 25.

3

Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents.葡萄糖-6-磷酸脱氢酶缺乏症患者接受药物洗脱支架PCI时的双联抗血小板治疗

J Atheroscler Thromb. 2015;22(5):535-41. doi: 10.5551/jat.29371. Epub 2015 Apr 3.

4

PCI patients taking oral anticoagulants may not need aspirin.

BMJ. 2013 Feb 20;346:f1052. doi: 10.1136/bmj.f1052.

5

Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention.葡萄糖-6-磷酸脱氢酶缺乏的急性冠状动脉综合征患者在接受经皮冠状动脉介入治疗时阿司匹林的安全性。

BMJ Case Rep. 2017 Oct 9;2017:bcr-2017-220483. doi: 10.1136/bcr-2017-220483.

6

Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.接受阿司匹林治疗的经皮冠状动脉介入治疗患者中，300毫克氯吡格雷的早期抗血小板作用有限。

Eur Heart J. 2004 Mar;25(6):476-83. doi: 10.1016/j.ehj.2003.12.016.

7

Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.药物洗脱支架经皮冠状动脉介入术后改良双联抗血小板治疗联合华法林的疗效

J Invasive Cardiol. 2010 Feb;22(2):80-3.

8

Efficacy and safety of triple-antiplatelet therapy after percutaneous coronary intervention: a meta-analysis.经皮冠状动脉介入治疗后三联抗血小板治疗的疗效和安全性：一项荟萃分析。

Chin Med J (Engl). 2013;126(9):1750-4.

9

Efficacy of cilostazol in patients with acute coronary syndrome after percutaneous coronary intervention.西洛他唑治疗经皮冠状动脉介入治疗后急性冠状动脉综合征患者的疗效。

Am J Ther. 2013 Mar-Apr;20(2):151-3. doi: 10.1097/MJT.0b013e31825a3616.

10

[The WOEST study].

G Ital Cardiol (Rome). 2013 Sep;14(9):564-8. doi: 10.1714/1311.14481.

引用本文的文献

1

Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients.葡萄糖-6-磷酸脱氢酶（G6PD）缺乏症患者急性缺血性脑卒中后阿司匹林诱导的血红蛋白下降与结局的关系。

CNS Neurosci Ther. 2021 Oct;27(10):1206-1213. doi: 10.1111/cns.13711. Epub 2021 Aug 8.

2

Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?葡萄糖-6-磷酸脱氢酶缺乏症患者的心血管疾病中应用阿司匹林治疗：安全吗？

Am J Cardiovasc Drugs. 2021 Jul;21(4):377-382. doi: 10.1007/s40256-020-00460-8. Epub 2020 Dec 14.

3

Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention.葡萄糖-6-磷酸脱氢酶缺乏的急性冠状动脉综合征患者在接受经皮冠状动脉介入治疗时阿司匹林的安全性。

BMJ Case Rep. 2017 Oct 9;2017:bcr-2017-220483. doi: 10.1136/bcr-2017-220483.

4

An agent-based model of the response to angioplasty and bare-metal stent deployment in an atherosclerotic blood vessel.一种基于代理的动脉粥样硬化血管中血管成形术和裸金属支架植入反应模型。

PLoS One. 2014 Apr 14;9(4):e94411. doi: 10.1371/journal.pone.0094411. eCollection 2014.